<DOC>
	<DOCNO>NCT00898430</DOCNO>
	<brief_summary>RATIONALE : Studying sample tumor tissue patient cancer laboratory may help doctor learn change occur DNA identify biomarkers related cancer . It may also help doctor predict patient respond treatment . PURPOSE : This research study look biomarkers predict response treatment patient newly diagnose stage III stage IV head neck cancer treat carboplatin , paclitaxel , radiation therapy .</brief_summary>
	<brief_title>Biomarkers Predicting Response Treatment Patients With Newly Diagnosed Stage III Stage IV Head Neck Cancer Treated With Carboplatin , Paclitaxel , Radiation Therapy</brief_title>
	<detailed_description>OBJECTIVES : - Determine gene expression pattern correlate treatment response survival identify use DNA microarrays patient newly diagnose head neck squamous cell carcinoma ( HNSCC ) treat carboplatin , paclitaxel , radiotherapy . - Determine protein expression pattern correlate treatment response survival HNSCC identify use matrix-assisted laser desorption ionization-time-of-flight mass spectrometry ( MALDI-TOFMS ) . - Determine molecular signature human papilloma virus-16 infection determine use DNA microarray MALDI-TOFMS correlate gene protein expression , treatment response , survival . OUTLINE : Tumor tissue sample analyze DNA microarray analysis validate quantitative reverse transcription-polymerase chain reaction ( PCR ) . Protein gene expression pattern analyze laser desorption ionization-time-of-flight mass spectrometry , high performance liquid chromatography , liquid chromatography-tandem mass spectrometry , PCR . Samples also analyze tissue microarray immunohistochemistry .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Newly diagnose head neck squamous cell carcinoma Stage IIIIV disease Scheduled panendoscopy Tumor tissue available patient treat carboplatin , paclitaxel , radiotherapy protocol VUVICCHN0356 PATIENT CHARACTERISTICS : Able speak English PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>stage III squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage III squamous cell carcinoma larynx</keyword>
	<keyword>stage III verrucous carcinoma larynx</keyword>
	<keyword>stage IV squamous cell carcinoma larynx</keyword>
	<keyword>stage IV verrucous carcinoma larynx</keyword>
	<keyword>stage III squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage IV squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage III verrucous carcinoma oral cavity</keyword>
	<keyword>stage IV verrucous carcinoma oral cavity</keyword>
	<keyword>metastatic squamous neck cancer occult primary squamous cell carcinoma</keyword>
	<keyword>untreated metastatic squamous neck cancer occult primary</keyword>
	<keyword>stage III squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage III squamous cell carcinoma oropharynx</keyword>
	<keyword>stage IV squamous cell carcinoma oropharynx</keyword>
	<keyword>stage III squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>stage IV squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>salivary gland squamous cell carcinoma</keyword>
	<keyword>stage III salivary gland cancer</keyword>
	<keyword>stage IV salivary gland cancer</keyword>
</DOC>